Overweight

Showing NaN - NaN of 39

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Obesity, Overweight Trial in United States (LY3305677, Placebo)

Not yet recruiting
  • Obesity
  • Overweight
  • Mesa, Arizona
  • +27 more
Nov 21, 2023

Overweight, Obese, Type 1 Diabetes Trial in United States (CT-868, CT-868 Pen Injector, : CT-868 Pen Injector, Placebo)

Not yet recruiting
  • Overweight
  • +2 more
  • La Jolla, California
  • +15 more
Sep 29, 2023

Overweight, Obesity Trial in United States (Tirzepatide, Placebo)

Not yet recruiting
  • Overweight
  • Obesity
  • Pelham, Alabama
  • +19 more
Sep 14, 2023

Type 2 Diabetes, Obesity, Overweight Trial in Worldwide (Retatrutide, Placebo)

Not yet recruiting
  • Type 2 Diabetes
  • +3 more
  • Los Angeles, California
  • +91 more
Jul 10, 2023

Obesity, Overweight, Osteo Arthritis Knee Trial in Worldwide (Retatrutide, Placebo)

Not yet recruiting
  • Obesity
  • +2 more
  • Phoenix, Arizona
  • +67 more
Jul 10, 2023

Obesity, Overweight, Type 2 Diabetes Trial in Worldwide (Orforglipron, Placebo)

Not yet recruiting
  • Obesity
  • +2 more
  • Pelham, Alabama
  • +135 more
May 15, 2023

Obesity, Overweight, Overweight or Obesity Trial in Worldwide (Orforglipron, Placebo)

Not yet recruiting
  • Obesity
  • +2 more
  • Mesa, Arizona
  • +134 more
May 12, 2023

Obesity, Overweight Trial in Puerto Rico, United States (Tirzepatide, Semaglutide 2.4 mg)

Recruiting
  • Obesity
  • Overweight
  • Birmingham, Alabama
  • +31 more
Apr 26, 2023

Type 2 Diabetes, Obesity, Overweight or Obesity Trial in Worldwide (Orforglipron, Insulin Glargine)

Recruiting
  • Type 2 Diabetes
  • +5 more
  • Muscle Shoals, Alabama
  • +320 more
Apr 12, 2023

Overweight, Obesity and Diabetes, Type 2 Trial (Cagrilintide, Semaglutide, Placebo cagrilintide)

Not yet recruiting
  • Overweight
  • +2 more
  • Concord, California
  • +147 more
Jan 24, 2023

Overweight, Obesity Trial (Semaglutide, Placebo semaglutide)

Active, not recruiting
  • Overweight
  • Obesity
  • Birmingham, Alabama
  • +21 more
Jan 24, 2023

Obesity, Overweight Trial in Worldwide (Tirzepatide, Placebo)

Recruiting
  • Obesity
  • Overweight
  • Gilbert, Arizona
  • +695 more
Jan 18, 2023

Overweight, Obesity Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Active, not recruiting
  • Overweight
  • Obesity
  • Birmingham, Alabama
  • +804 more
Dec 19, 2022

Overweight Trial in United States (RM-493, Placebo)

Completed
  • Overweight
  • Miami, Florida
  • +5 more
Nov 14, 2022

Overweight, Obesity Trial in Worldwide (Gelesis100, )

Completed
  • Overweight
  • Obesity
  • Gelesis100
  • placebo
  • Anaheim, California
  • +35 more
Aug 8, 2022

Obesity, Overweight Trial in Puerto Rico, United States (LY3437943, Placebo)

Active, not recruiting
  • Obesity
  • Overweight
  • Scottsdale, Arizona
  • +27 more
May 10, 2022

Overweight, Obesity Trial in United States (Semaglutide, Placebo (semaglutide), Liraglutide)

Completed
  • Overweight
  • Obesity
  • Birmingham, Alabama
  • +18 more
Apr 26, 2022

Type 2 Diabetes, Overweight, Obesity Trial in Worldwide (Tirzepatide, Placebo)

Active, not recruiting
  • Type 2 Diabetes
  • +2 more
  • Birmingham, Alabama
  • +74 more
Apr 18, 2022

Overweight, Obesity Trial in Worldwide (Tirzepatide, Placebo)

Active, not recruiting
  • Overweight
  • Obesity
  • Pelham, Alabama
  • +119 more
Apr 12, 2022

Pulmonary Disease, Chronic Obstructive, Obesity, Weight Loss Trial in United States (Lifestyle Intervention)

Completed
  • Pulmonary Disease, Chronic Obstructive
  • +4 more
  • Lifestyle Intervention
  • Birmingham, Alabama
  • +38 more
Mar 10, 2022

Obesity, Overweight Trial in Worldwide (Tirzepatide, Placebo)

Active, not recruiting
  • Obesity
  • Overweight
  • Huntington Park, California
  • +64 more
Mar 22, 2022

Overweight, Obesity Trial in United States

Recruiting
  • Overweight
  • Obesity
    • Little Rock, Arkansas
    • +27 more
    Feb 11, 2022

    Obesity, Overweight Trial in Worldwide (Oral semaglutide, Placebo (semaglutide))

    Active, not recruiting
    • Obesity
    • Overweight
    • Oral semaglutide
    • Placebo (semaglutide)
    • Birmingham, Alabama
    • +50 more
    Jan 26, 2022

    Overweight, Obesity Trial in United States (Semaglutide, Placebo (semaglutide))

    Completed
    • Overweight
    • Obesity
    • Birmingham, Alabama
    • +40 more
    Nov 10, 2021

    Obesity, Overweight Trial in Worldwide (Semaglutide 1.0 mg, Semaglutide 2.4 mg, Placebo I (Semaglutide))

    Completed
    • Obesity
    • Overweight
    • Semaglutide 1.0 mg
    • +3 more
    • Buena Park, California
    • +146 more
    Nov 8, 2021